TECK Human

Thymus Expressed Chemokine Human Recombinant (CCL25)
Shipped with Ice Packs
In Stock

Description

Teck’s Human Health Risk Assessments (HHRAs)

Teck conducts rigorous environmental and human health risk evaluations for contaminants linked to its mining operations. These assessments focus on exposure pathways, toxicity thresholds, and mitigation strategies. Key examples include:

Lead (Pb) Exposure in Trail, BC

  • Objective: Assess risks from historical and contemporary lead emissions from Teck’s Trail smelter operations .

  • Methodology:

    • Evaluated Pb in soil, dust, and air across residential neighborhoods .

    • Modeled exposure scenarios: Reasonable Maximum (conservative), Central Tendency (average), and Protocol 1 (regulatory compliance) .

    • Compared predicted blood lead levels (BLLs) with 22 years of measured BLL data .

Table 1: Key HHRA Findings for Lead3

  • Outcome: The Central Tendency scenario aligns with measured BLL declines (attributed to Teck’s Trail Area Health & Environment Program) .

Selenium in the Elk Valley, BC

  • Focus: Risks from selenium leaching into watersheds near Teck’s coal mines .

  • Key Data:

    • Selenium concentrations in local fish averaged 1.2–3.1 mg/kg, exceeding safe consumption thresholds .

    • Daily fish consumption (1 meal/day) poses risks of selenosis (hair loss, neurological effects) .

Table 2: Selenium Exposure Risk by Consumption Frequency7

FrequencyToddler HQ*Adult HQ*
Daily (1 meal)1.8–2.51.1–1.6
Monthly (3 meals)0.2–0.30.1–0.2

*HQ = Hazard Quotient (HQ > 1 indicates risk)

  • Mitigation: Teck’s Elk Valley Water Quality Plan targets selenium reduction through water treatment and waste rock management .

Teck-Funded Human Health Research

Teck supports academic and applied research through programs like the TeCK Fund at Cleveland State University:

  • Objective: Commercialize technologies addressing health and environmental challenges .

  • Notable Projects:

    1. PACTS System: Privacy-aware compliance tracking for elder care (Dr. Wenbing Zhao) .

    2. 3D Bioprinting: Miniaturized human cell models for drug testing (Dr. Moo-Yeal Lee) .

    3. Rapid Infection Diagnosis: Culture-free platform for bloodstream/UTI detection (Dr. Siu-Tung Yau) .

Regulatory and Community Engagement

Teck collaborates with governments and Indigenous groups to address health risks:

  • Partnerships: Workgroups include BC Ministry of Environment, Interior Health, and Ktunaxa Nation .

  • Adaptive Management: Ongoing monitoring and adjustments to water quality plans based on HHRA outcomes .

Controversies and Criticisms

  • Selenium Standards: BC has yet to align with Montana’s stricter selenium limits (0.8 µg/L vs. 1.0 µg/L) .

  • Legacy Contamination: Persistent Pb in soil/dust in Trail neighborhoods despite remediation efforts .

Product Specs

Introduction
CCL25, also known as TECK, is a CC chemokine with limited similarity (around 20% amino acid sequence identity) to other chemokines within the same family. Both human and mouse CCL25 have been cloned. Human CCL25 is a 144 amino acid protein while mouse CCL25 is 144 amino acids in length and shares 49% sequence identity with its human counterpart. Expression of CCL25 is highly restricted, primarily observed in the thymus and small intestine. Within the thymus, dendritic cells are the main producers of CCL25, however, bone marrow-derived dendritic cells do not express it. CCL25 exerts its effects by signaling through the CCR9 receptor and is believed to play a role in T-cell development. Studies using recombinant human and mouse CCL25 have demonstrated its chemotactic properties, attracting activated macrophages, dendritic cells, and thymocytes. Furthermore, the recombinant protein exhibits chemotactic activity towards thymocytes, macrophages, THP-1 cells (a human monocytic cell line), and dendritic cells, while showing no activity on peripheral blood lymphocytes or neutrophils.
Description
Recombinant human TECK, expressed in E. coli, is a single, non-glycosylated polypeptide chain composed of 127 amino acids. It has a molecular weight of 14.2 kDa. The purification process of TECK involves proprietary chromatographic techniques.
Physical Appearance
White, lyophilized (freeze-dried) powder that has been sterile filtered.
Formulation
The protein solution, at a concentration of 1 mg/ml in 20 mM phosphate buffer (PB) at pH 7.4 containing 150 mM NaCl, is filtered through a 0.2 µm filter and subsequently lyophilized.
Solubility
To reconstitute the lyophilized TECK, it is recommended to dissolve it in sterile 18 MΩ-cm H2O at a minimum concentration of 100 µg/ml. Once reconstituted, the solution can be further diluted in other aqueous solutions as needed.
Stability
Lyophilized TECK remains stable at room temperature for a period of 3 weeks. However, for long-term storage, it is recommended to store the lyophilized powder desiccated at a temperature below -18°C. After reconstitution, the TECK solution should be stored at 4°C for a period of 2-7 days. For extended storage, it is recommended to freeze the solution at -18°C. To enhance stability during long-term storage, the addition of a carrier protein such as 0.1% HSA or BSA is advised. It is important to avoid repeated freeze-thaw cycles.
Purity
The purity of the protein is greater than 97.0%, as determined by the following methods:
(a) Reverse-phase high-performance liquid chromatography (RP-HPLC) analysis.
(b) Sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis.
Biological Activity
The biological activity of the protein is assessed based on its ability to induce chemotaxis in human monocytes. Activity is determined within a concentration range of 1-10 ng/ml. This corresponds to a specific activity ranging from 100,000 to 1,000,000 IU/mg.
Synonyms
C-C motif chemokine 25, Small-inducible cytokine A25, Thymus-expressed chemokine, Chemokine TECK, CCL25, SCYA25, TECK, Ckb15, MGC150327.
Source
Escherichia Coli.
Amino Acid Sequence
QGVFEDCCLA YHYPIGWAVL RRAWTYRIQE VSGSCNLPAA IFYLPKRHRK VCGNPKSREV QRAMKLLDAR NKVFAKLHHN MQTFQAGPHA VKKLSSGNSK LSSSKFSNPI SSSRKNVSLL ISANSGL.

Q&A

What are the essential components of a comprehensive human health risk assessment for metal exposure?

A robust human health risk assessment (HHRA) for metal exposure, such as the lead (Pb) assessments conducted by Teck Metals Ltd., requires several methodological components. The assessment begins with problem formulation, which includes defining the environmental setting, screening contaminants of potential concern (COPC), analyzing exposure pathways, and developing a conceptual site model that connects sources to receptors . The exposure assessment phase requires determining concentration points in various media (soil, dust, air), characterizing receptor behaviors (including age-specific factors), and calculating exposure rates . This is followed by toxicity assessment, which establishes reference values, and risk characterization, which compares estimated exposures to acceptable thresholds.

The most critical pathways typically include direct soil ingestion (particularly relevant for children due to hand-to-mouth behaviors), dust ingestion, and inhalation of particulate matter containing adsorbed metals . A scientifically sound assessment must consider bioavailability factors that influence how much of the metal is actually absorbed by the body through different exposure routes.

How should researchers determine appropriate receptor characteristics in health risk assessments?

Determining appropriate receptor characteristics requires a methodical approach based on demographic data and exposure science. Researchers must first identify relevant age groups with distinct behavioral and physiological characteristics. The HHRA approach used in the Teck Metals assessment systematically defined age-specific parameters including body weight, soil ingestion rates, dust ingestion rates, air inhalation rates, and time-activity patterns (indoor vs. outdoor time) .

For children, who often represent the most vulnerable population due to higher ingestion rates relative to body weight and developing physiological systems, special consideration must be given to hand-to-mouth behaviors and developmental stage. Researchers should utilize age-specific exposure factors from authoritative sources while considering local behavioral patterns that might differ from generic values. The assessment should incorporate variability within populations and potentially identify highly exposed subgroups within the general population.

What experimental approaches help distinguish between exposure sources when analyzing biomarkers in human populations?

Distinguishing between multiple exposure sources requires sophisticated experimental approaches that combine analytical chemistry with statistical modeling. Researchers should employ isotopic ratio analysis, which can fingerprint different industrial sources of metals based on their characteristic isotopic signatures. This approach is particularly valuable in areas with multiple potential sources, such as the vicinity of operations like Teck Metals .

Another powerful approach involves the collection of paired environmental and biomarker samples, establishing source-specific correlation patterns. This can be complemented by multielement analysis that examines patterns of co-occurring elements characteristic of specific sources. Advanced statistical methods like principal component analysis (PCA), positive matrix factorization (PMF), and structural equation modeling can help researchers disentangle the contribution of different sources to observed biomarker levels.

Temporal patterns in exposure markers can also provide insights, especially when industrial emissions follow predictable patterns that differ from other sources. For definitive source apportionment, controlled exposure studies in laboratory settings may be necessary to establish clear relationships between source-specific exposures and resulting biomarker patterns.

How can researchers effectively model bioavailability differences across exposure pathways?

Modeling bioavailability differences across exposure pathways requires integration of physicochemical and physiological factors. For oral bioavailability, researchers should develop in vitro bioaccessibility tests that simulate the human digestive environment, with particular attention to pH progression, enzyme activity, and solid-to-fluid ratios that mirror physiological conditions . These methods must be validated against in vivo data when available.

For inhalation pathways, models must account for particle size distribution, deposition patterns in different regions of the respiratory tract, and dissolution kinetics in lung fluids. Sophisticated physiologically-based pharmacokinetic (PBPK) models can integrate pathway-specific absorption parameters and internal distribution processes to predict target tissue doses from external exposure concentrations.

Importantly, researchers should consider metal speciation, as different chemical forms of the same metal can have dramatically different bioavailability profiles. Advanced spectroscopic techniques and sequential extraction procedures can help characterize the speciation of metals in environmental media before modeling bioavailability. Mathematical models should incorporate adjustment factors for matrix effects, such as the influence of soil organic matter or binding to food components, which can significantly alter bioavailability.

What methodological approaches are most effective for studying how mechanical cues influence cancer cell behavior?

The study of mechanical influences on cancer cell behavior requires interdisciplinary approaches combining engineering principles with cell biology. Professor Lim Chwee Teck's research demonstrates that effective methodologies include the development of microfluidic platforms that precisely control geometric constraints and spatial organization of ECM proteins . These platforms allow for systematic manipulation of mechanical parameters while observing cellular responses in real-time.

Quantitative live-cell imaging techniques are essential for tracking dynamic cell behaviors, including migration velocity, directional persistence, and morphological adaptations. These should be combined with molecular readouts of mechanotransduction pathways, such as YAP/TAZ nuclear localization or focal adhesion dynamics. Researchers should employ traction force microscopy or similar techniques to measure cellular forces exerted on substrates of varying stiffness, correlating these mechanical outputs with invasive potential.

Comparative studies between normal and cancer cells exposed to identical mechanical environments can reveal cancer-specific responses, as demonstrated by MBI scientists who found that ECM topography affects proliferation differently in normal versus cancer cells . Advanced techniques include atomic force microscopy to map cellular mechanical properties and the use of optogenetic tools to precisely control mechanosensitive signaling with spatial and temporal precision.

How should researchers design experiments to investigate collective cell migration in confined spaces?

Designing experiments to investigate collective cell migration in confined spaces requires careful consideration of microenvironmental parameters and analytical approaches. Based on the work at MBI under Professor Lim Chwee Teck's leadership, researchers should develop microfluidic devices that create well-defined confinement geometries, allowing for systematic variation of channel width, height, and curvature .

The experimental design should include:

  • Cell sheet engineering techniques to establish well-defined initial conditions

  • Time-lapse imaging with sufficient temporal resolution to capture leader-follower dynamics

  • Fluorescent reporters for visualization of cell-cell junctions, cytoskeletal elements, and nuclear positioning

  • Image analysis algorithms for quantifying collective behaviors (velocity correlations, order parameters)

  • Perturbation approaches using pharmacological inhibitors or genetic manipulations to target specific mechanotransduction pathways

Particularly informative are comparative studies between different cell types (e.g., epithelial vs. mesenchymal) and conditions (e.g., normal vs. malignant). Advanced approaches include the introduction of controlled mechanical or chemical gradients perpendicular to the direction of confinement, creating competing cues that reveal prioritization in cellular decision-making.

The analysis should incorporate both population-level metrics and single-cell resolution data to understand emergent behaviors. This comprehensive approach enables researchers to uncover the mechanisms by which cells collectively migrate in specific directions within geometrical constraints, potentially leading to therapeutic strategies for diseases like cancer or tissue repair .

What criteria should guide the development of microfluidic technologies for disease diagnosis?

The development of microfluidic technologies for disease diagnosis should be guided by both technical and translational criteria. Professor Lim Chwee Teck's extensive work in this field suggests that successful microfluidic diagnostic platforms should achieve high sensitivity and specificity for the target biomarkers while maintaining reproducibility across samples and devices .

Technical considerations should include:

  • Sample preparation requirements (volume, pre-processing steps)

  • Flow control precision and reliability

  • Material biocompatibility and optical properties

  • Integration capability with detection systems

  • Manufacturability and scalability potential

From a translational perspective, developers should prioritize:

  • Clinical relevance of the targeted biomarkers

  • Improvement over existing diagnostic approaches (in sensitivity, speed, cost, or accessibility)

  • Compatibility with clinical workflow and infrastructure

  • Potential for point-of-care application

  • Regulatory pathway considerations

Validation should occur in stages, beginning with analytical validation using standard samples, progressing to testing with clinical samples, and culminating in comparative studies against gold standard methods. Throughout development, researchers should maintain close collaboration with clinicians to ensure the technology addresses genuine clinical needs rather than solely pursuing technical innovation.

How can researchers effectively validate wearable technologies for human disease monitoring?

Effective validation of wearable technologies for disease monitoring requires a comprehensive approach addressing both technical performance and clinical utility. Based on Professor Lim Chwee Teck's research in soft wearable technologies for biomedical applications, the validation process should begin with rigorous laboratory testing of sensor performance metrics including accuracy, precision, linearity, and detection limits under controlled conditions .

The validation methodology should then progress through several phases:

  • Technical validation:

    • Stability testing under varied environmental conditions (temperature, humidity)

    • Assessment of motion artifacts and interference from other physiological parameters

    • Evaluation of power consumption and battery life

    • Durability and reliability testing with repeated use

  • Controlled human studies:

    • Comparison against clinical gold standards

    • Evaluation in healthy volunteers under various activity levels

    • Assessment of user comfort and wearability

    • Data collection to establish normal ranges and variability

  • Clinical validation:

    • Testing in relevant patient populations

    • Longitudinal monitoring to assess prognostic value

    • Investigation of correlation between wearable metrics and clinical outcomes

    • Evaluation of the technology's ability to detect meaningful changes in disease state

Throughout this process, researchers should employ statistical methods appropriate for method comparison studies, such as Bland-Altman analysis, and account for both individual and temporal variability. Validation should also include usability assessment and consideration of data security and privacy aspects, particularly for technologies that transmit health information wirelessly.

How does the increasing anthropomorphization of technology in academic research affect study design and interpretation?

The increasing anthropomorphization of technology in academic research has significant implications for study design and interpretation. Research by Cheng and colleagues at Stanford University reveals that academic publications are increasingly using human pronouns and human-characteristic verbs when describing technology, particularly artificial intelligence . This trend raises important methodological concerns for researchers.

When designing studies involving advanced technologies, researchers should carefully consider language choices in research instruments, ensuring that anthropomorphic framing doesn't bias participant responses. Experimental designs should include controls for anthropomorphic presentation, potentially comparing responses to identical technologies presented with either neutral or anthropomorphic descriptions.

For interpretation, researchers must remain vigilant about whether observed effects stem from the technology itself or from the anthropomorphic framing that creates specific expectations. Critical analysis should distinguish between functional affordances of technologies and perceived "human-like" qualities that may not represent actual capabilities.

This awareness is particularly important for studies examining human-technology interaction, where anthropomorphic framing can significantly impact trust, acceptance, and usage patterns. Researchers should strive for precision in describing technological capabilities, avoiding language that might mislead the public or other researchers about the actual capabilities of artificial intelligence and other technologies .

What methodological approaches best capture the interdisciplinary nature of human-technology interaction research?

Capturing the interdisciplinary nature of human-technology interaction research requires methodological approaches that bridge technical and social science perspectives. Based on emerging research trends, the most effective approaches integrate multiple methods and theoretical frameworks from different disciplines.

Mixed-methods designs combining quantitative performance metrics with qualitative insights from interviews, observations, or think-aloud protocols provide complementary data types that enrich understanding. Interdisciplinary research teams including both technical experts (engineers, computer scientists) and human behavior specialists (psychologists, anthropologists, ethicists) ensure research questions and designs reflect diverse perspectives.

Longitudinal studies examining how human-technology relationships evolve over time are particularly valuable, as they capture adaptation processes and changing perceptions. Ecological validity should be prioritized through in-situ studies in natural environments rather than laboratory-only investigations.

Additionally, participatory research methods involving end-users as co-researchers rather than merely subjects help ensure technologies are developed with genuine human needs in mind. For analysis, researchers should employ frameworks that explicitly acknowledge the socio-technical nature of the systems being studied, recognizing that technologies exist within social contexts that shape their use and meaning.

This comprehensive methodological approach aligns with the work of researchers like Professor Lim Chwee Teck, who employs interdisciplinary methods to develop technologies that address human needs in healthcare contexts .

Product Science Overview

Structure and Expression

CCL25 is produced as a protein precursor containing 151 amino acids . The recombinant human CCL25 protein is typically expressed in E. coli and consists of 127 amino acids with a molecular weight of approximately 14.2 kDa . It is highly purified, with a purity greater than 98% as determined by SDS-PAGE .

Function and Mechanism

CCL25 is primarily involved in the chemotactic response, meaning it directs the movement of immune cells towards areas where they are needed. It is chemotactic for thymocytes, macrophages, and dendritic cells . This chemokine exerts its effects by binding to the chemokine receptor CCR9 . The interaction between CCL25 and CCR9 is essential for the navigation and trafficking of developing T cells within the thymus .

In addition to its role in the thymus, CCL25 is also expressed in the small intestine, where it helps regulate the immune response in the gut . Dendritic cells in the thymus are identified as the primary source of CCL25 production, although bone marrow-derived dendritic cells do not express this chemokine .

Applications in Research

Recombinant human CCL25 is widely used in research to study its role in immune cell trafficking and development. It is utilized in various assays, including Western blot, immunohistochemistry, ELISA, and functional assays . The activity of recombinant CCL25 is often determined by its ability to bind to the CCR9 receptor on the surface of specific cell lines, such as MOLT4 cells .

Storage and Handling

Recombinant human CCL25 is typically supplied in a lyophilized form and should be reconstituted in water to a concentration of 0.1-1.0 mg/mL . It is recommended to store the reconstituted protein at 2°C to 8°C for up to one week or at -20°C to -80°C for long-term storage . Avoid repeated freeze-thaw cycles to maintain protein stability .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.